V-Square Quantitative Management’s AbbVie ABBV Stock Holding History

V-Square Quantitative Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.26M	Buy	12,467 +1,256	+11%	+$322K	0.3%	47
2026 Q2	$2.82M	Buy	11,211 +3,471	+45%	+$747K	0.27%	55
2026 Q1	$1.68M	Buy	7,740 +447	+6%	+$99.2K	0.18%	95
2025 Q4	$1.67M	Sell	7,293 -3,774	-34%	-$860K	0.17%	90
2025 Q3	$2.56M	Buy	11,067 +1,205	+12%	+$245K	0.43%	46
2025 Q2	$1.83M	Sell	9,862 -349	-3%	-$64.9K	0.25%	78
2025 Q1	$2.14M	Sell	10,211 -903	-8%	-$176K	0.31%	58
2024 Q4	$1.97M	Buy	11,114 +350	+3%	+$64.4K	0.28%	63
2024 Q3	$2.13M	Buy	10,764 +2,167	+25%	+$404K	0.31%	56
2024 Q2	$1.47M	Sell	8,597 -47	-0.5%	-$7.78K	0.24%	72
2024 Q1	$1.57M	Buy	8,644 +7,210	+503%	+$1.24M	0.22%	66
2023 Q4	$222K	Hold	1,434	–	–	0.04%	403
2023 Q3	$214K	Buy	1,434 +1,296	+939%	+$190K	0.09%	285
2023 Q2	$18.6K	Buy	+138	New	+$20.2K	0.01%	378

Other funds holding ABBV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

V-Square Quantitative Management's ABBV Position: Q3 2026 in Review

V-Square Quantitative Management increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $322K and bringing the position to 12,467 shares worth $3.26M. The position accounts for 0.3% of the portfolio, ranked #47.

V-Square Quantitative Management first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. 966 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

V-Square Quantitative Management held 12,467 shares of AbbVie worth $3.26M as of Q3 2026.
V-Square Quantitative Management bought 1,256 AbbVie shares in Q3 2026, an estimated $322K.
AbbVie made up 0.3% of V-Square Quantitative Management's portfolio in Q3 2026, its #47 holding.
V-Square Quantitative Management first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
966 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.